<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
 <url>
  <loc>https://www.dottnet.it/articolo/32543708/farmacovigilanza-ema-aggiorna-il-modulo-iii-delle-gvp-ispezioni-anche-sulle-attivita-affidate-a-terzi</loc>
  <lastmod>2026-09-14T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Farmacovigilanza, EMA aggiorna il Modulo III delle GVP: ispezioni anche sulle attività affidate a terzi</news:title>
   <news:publication_date>2026-09-14</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543708-28759.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543710/schillaci-sanita-fuori-dal-debito-per-il-7-servono-20-miliardi</loc>
  <lastmod>2026-09-14T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Schillaci: sanità fuori dal debito, per il 7% servono 20 miliardi</news:title>
   <news:publication_date>2026-09-14</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543710-schillaci.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543709/tumori-l-europa-resta-forte-nella-ricerca-ma-perde-terreno-nei-trial-oncologici</loc>
  <lastmod>2026-09-14T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Tumori, l’Europa resta forte nella ricerca ma perde terreno nei trial oncologici</news:title>
   <news:publication_date>2026-09-14</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543709-anteprimearticolidottnet-2026-09-14t095258593.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543711/fda-quadro-dirigenziale-rinnovato-intelligenza-artificiale-farmaci-biologici-e-tabacco-i-quattro-fronti-strategici</loc>
  <lastmod>2026-09-14T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>FDA, quadro dirigenziale rinnovato: intelligenza artificiale, farmaci, biologici e tabacco i quattro fronti strategici</news:title>
   <news:publication_date>2026-09-14</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543711-33ea0e4a-68bc-46bc-a3b5-924376c6abe3.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543712/schillaci-piu-poteri-al-ministero-per-frenare-le-disparita-regionali</loc>
  <lastmod>2026-09-14T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Schillaci: più poteri al ministero per frenare le disparità regionali</news:title>
   <news:publication_date>2026-09-14</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543712-schillaci.jpg</image:loc>
  </image:image>
 </url>
</urlset>